Devenir membre

Devenir membre

Espace membre

Espace membre

évènements

évènements

3rd edition of Immunology Days


mardi 10 décembre 2024 | 9h00 - 17h00

Eurobiomed is pleased to invite you to the 3rd edition of Immunology Days, to be held at the EMD in Marseille. Under the theme “ All committed to the development of immune therapies against cancer, inflammatory and infectious diseases ”, this year’s event will bring together key players from research and industry to advance innovations in immunology. This unique event offers a space dedicated to exchanging knowledge and sharing scientific advances in the field of immunology. Participants will be able to attend presentations of innovative projects and discover new perspectives on immune therapies, all in a setting conducive to scientific interaction.

PROGRAM

09:00
09:00

Welcome

09:30
09:30

Introduction

Eric VACARESSE - President, Eurobiomed

09:40
09:40

Words from local authorities

10:00
10:00

An update : MIB, an International Biocluster in Immunology

Pr Daniel OLIVE - MD PhD, Aix-Marseille Université

Part 1: Ambition to accelerate, target discovery, validation and success

10:20
10:20

Beacon: a bed-to-bench approach to revealed original targets for antibody-based therapy,

François ROMAGNÉ - Directeur Scientifique, MimAbs

10:50
10:50

Title to be confirmed,

Pr. Bernard MALISSEN

11:20
11:20

Aix Marseille Université (Name to be confirmed)

11:50
11:50

C2IT, When IPC and APHM join forces to reinforce clinical trials in immunology

Pr Norbert VEY - Managing Director, Institut Paoli-Calmettes & Emilie GARRIDO PRADALIE - Directrice Recherche en Santé et Maladies Rares, Assistance Publique - Hôpitaux de Marseille

Lunch and Networking

13 : 45
13 : 45

Key Note : Sanofi, a global strategy to target immune-diseases,

Frédéric MARRACHE - VP -Global Project Head - Clinical Development - Immunology and Inflammation Therapeutic Area, SANOFI

Part 2: A hub of industrial innovation

14:15
14:15

Remora Biotech Venture Builder : new generation of first-in class and multifunctional immunotherapy products to treat cancer and AID

 Mr David BECHARD- PhD CEO,  Remora Biotech France – Nanomunity – Radiomune Pharma

14:45
14:45

Imcheck Therapeutics

Name to be confirmed

15:15
15:15

GTP bioways

Mr Eric DEVIC - PhD CEO, GTP Bioways

15:45
15:45

New opportunities for democratizing the use of flow cytometry

 Mr Fabrice MALERGUE- PhD Senior Staff Research Scientist, Beckman Coulter Life Sciences/ Immunotech

16:15
16:15

Networking

17:00
17:00

End

About MIB

Located at the center of Marseille, home of immunology research for over 40 years, the mission of MIB is to develop and implement cooperation between all stakeholders of tomorrow’s immunology at the national and international levels. Researchers, hospital practitioners, biotechs & pharma innovators, investors, students and public authorities will benefit from a dynamic environment (technology platforms, immunology start-up studios, support for SMEs and larger companies, etc.) and complementary expertise to develop cutting-edge immune-based therapies and new diagnostic tools. With a budget of €97 million as part of the France 2030 Plan, MIB aims to accelerate translational research in immunology, focusing on four therapeutic areas: oncology, infectiology, autoimmune and inflammatory diseases, for the benefit of patients.

MIB partners :

En partenariat avec :

Avec le soutien de :

Détails

Date :
mardi 10 décembre 2024
Heure :
9h00 - 17h00
Catégorie d’Évènement:
Évènement Tags:

Lieu

EMD Business School
Rue Joseph Biaggi
Marseille, 13003 France
+ Google Map

Pour plus de renseignements

Contactez-nous !